Internet of Events Leaderboard Traders Markets Hot Bets Surveillance Pricing

Log in Get Access

Accrue
/Home
/Manifold Markets
/27. Will FDA approve a COVID indication for fluvoxamine by the end of 2022?

ManifoldResolved: NOBINARY · cpmm-1

27. Will FDA approve a COVID indication for fluvoxamine by the end of 2022?

Yes4%

Yes Pool

$594

No Pool

$101

Resolution

NO

Probability

4%

Volume$1K

24h Volume$0

Liquidity$181

Traders15

CreatorACX Bot

ClosesJan 1, 2023

View on Manifold →Compare Across Platforms →

Accrue© 2026

Internet of Events Leaderboard Traders Markets Hot Bets Surveillance

The Intelligence Terminal for Prediction Markets

Terms Privacy Risk Disclosure Cookies Disclaimer Acceptable Use